Exploring IL-17 and IL-23 as biomarkers in H. pylori-linked gastric diseases: A cross-sectional study
Microbial Pathogenesis · 2025
DOI: 10.1016/j.micpath.2025.107741 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Microbial Pathogenesis, 2025. Verfasst von Refif Sabih Al-Shawk und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, College of Medicine, Mustansiriyah University, Iraq, Baghdad. Electronic address: refifalshawk@uomustansiriyah.edu.iq. Hauptthemen laut MEDLINE: Interleukin-17, Helicobacter Infections, Helicobacter pylori, Interleukin-23. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, College of Medicine, Mustansiriyah University, Iraq, Baghdad. Electronic address: refifalshawk@uomustansiriyah.edu.iq.
- Department of Microbiology, College of Medicine, Mustansiriyah University, Iraq, Baghdad. Electronic address: wasan.altaie@uomustansiriyah.edu.iq.
- Department of Microbiology, College of Medicine, Mustansiriyah University, Iraq, Baghdad. Electronic address: zahraaamohammed@uomustansiriyah.edu.iq.
Zitieren
APA
Al-Shawk, R. S., Bakir, W. A. E., & Mohammed, Z. A. (2025). Exploring IL-17 and IL-23 as biomarkers in H. pylori-linked gastric diseases: A cross-sectional study. Microbial Pathogenesis. https://doi.org/10.1016/j.micpath.2025.107741
Vancouver
Al-Shawk RS, Bakir WAE, Mohammed ZA. Exploring IL-17 and IL-23 as biomarkers in H. pylori-linked gastric diseases: A cross-sectional study. Microbial Pathogenesis. 2025. doi:10.1016/j.micpath.2025.107741
BibTeX
@article{AlShawk2025,
author = {Al-Shawk, Refif Sabih and Bakir, Wasan Abdul Elah and Mohammed, Zahraa A},
title = {Exploring IL-17 and IL-23 as biomarkers in H. pylori-linked gastric diseases: A cross-sectional study},
journal = {Microbial Pathogenesis},
year = {2025},
doi = {10.1016/j.micpath.2025.107741}
}
EUVIMED